Trypanosomiases;Les trypanosomoses

Revue du Praticien

Volumn 56, Issue 20, 2006, Pages 2209-2216

  Pelloux, Hervé ^a   Aznar, Christine ^b   Bouteille, Bernard ^c  

^a HÔPITAL MICHALLON   (France)

^b CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; EFLORNITHINE; MELARSOPROL; NIFURTIMOX; PENTAMIDINE; SURAMIN;

AFRICAN TRYPANOSOMIASIS; CHAGAS DISEASE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DISEASE TRANSMISSION; ENDEMIC DISEASE; HUMAN; PATHOGENESIS; PUBLIC HEALTH; REVIEW; RISK FACTOR; TRANSFUSION; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; ENDEMIC DISEASES; HUMANS; TRYPANOCIDAL AGENTS; TRYPANOSOMA; TRYPANOSOMIASIS; TRYPANOSOMIASIS, AFRICAN;

EID: 33846461708     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Jelinek T, Bisoffi Z, Bonazzi L, et al. Cluster of african trypanosomiasis in travelers to tanzanian national parks. Emerg Infect Di. 2002;8:634-5.
2. Barrett MP, Burchmore RJS, Stich A, et al. The trypanosomiases. Lancet 2003;362:1469-80.
3. Bouteille B, Dumas M. La trypanosomose humaine africaine: les défis à relever pour une maladie ré-émergente. Med Trop 1999;59:20S-4S.
4. Stich A, Abel M, Krishna S. Human african trypanosomiasis. Clin. Rev 2002;325:203-6.
5. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, et al. Transfusion-associated Chagas disease (american trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006;46:298-304.
6. Andrade LO, Andrews NW. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol 2005;3:819-23.
7. Louis FJ, Bouteille B, Simarro P, Buguet A. Résurgence de la maladie du sommeil. In Le risque biologique. Paris : Masson, 2004:85-102.
8. Anonyme. Trypanosomiase humaine africaine (maladie du sommeil) : mise à jour épidémiologique. Relevé Épidé miologique Hebdomadaire 2006;8:71-80.
9. Moncayo A. Chagas Disease: Current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003;98:577-91.
10. Coura JR, Junqueria AC, Fernandes O, Valente SA, Miles MA. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 2002;18:171-6.
11. Courtioux B, Bisser S, M'Belesso P, et al. Dot enzyme-linked immunosorbent assay for more reliable staging of patients with human african trypanosomiasis. J Clin Microbiol 2005;43:4789-95.
12. Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts : malaria, microsporidiosis, leishmaniasis, and african trypanosomiasis. Clin Infect Dis 2006;42:115-25.
13. Hontebeyrie M, Sepulveda P, Aznar C. Trypanosoma cruzi, agent de la maladie de Chagas ou trypanosomose américaine. Ann Inst Pasteur 1999;10:51-65.
14. Legros F, Ancelle T, réseau Anofel. Trypanosomiase humaine africaine : recensement des cas d'importation observés en France, 1980-2004. BEH 2006;7:57-9.
15. Cattand P. L'épidémiologie de la trypanosomiase humaine africaine : une histoire multifactorielle complexe. Med Trop 2001;61:313-22.
16. Louis FJ, Buscher P, Lejon V. Le diagnostic de la trypanosomiase humaine africaine en 2001. Med Trop 2001;61:340-6.
17. Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P. Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev 2005;18:133-46.
18. Ponce C, Ponce E, Vinelli E, et al. Validation of a rapid and reliable test for diagnosis of Chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in central america. J Clin Microbiol 2005;43:5065-8.
19. Aznar C, La Ruche G, Laventure S, Carme B, Liegeard P, Hontebeyrie M. Seroprevalence of Trypanosoma cruzi infection in french Guiana. Mem Inst Oswaldo Cruz 2004;99:805-8.
20. Benvenuti LA, Roggerio A, Sambiase NV, Fiorelli A, Higuchi M. Polymerase chain reaction in endomyocardial biopsies for monitoring reactivation of Chagas's disease in heart transplantation. A case report and review of the literature. Cardiovasc Pathol 2005;14:265-8.
21. Bouteille B, Oukem O, Bisser S, Dumas M. Treatment perspectives for human african trypanosomiasis. Fundam Clin Pharmacol 2003;17:171-81.
22. Coura JR, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002;97:3-24.
23. Urbiana JA, Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 2003;19:495-501.
24. Bhatia V, Garg N. Current status and future prospects for a vaccine against American trypanosomiasis. Expert Rev Vaccines 2005;4:867-80.